Journal article
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial
- Abstract:
-
Background: Hydroxychloroquine (HCQ) has proved ineffective in treating patients hospitalised with Coronavirus Disease 2019 (COVID-19), but uncertainty remains over its safety and efficacy in chemoprevention. Previous chemoprevention randomised controlled trials (RCTs) did not individually show benefit of HCQ against COVID-19 and, although meta-analysis did suggest clinical benefit, guidelines recommend against its use. Methods and findings: Healthy adult participants from the healthcare sett...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.8MB, Terms of use)
-
(Preview, Other, pdf, 1.3MB, Terms of use)
-
- Publisher copy:
- 10.1371/journal.pmed.1004428
Authors
- Publisher:
- Public Library of Science
- Journal:
- PLoS Medicine More from this journal
- Volume:
- 21
- Issue:
- 9
- Article number:
- e1004428
- Publication date:
- 2024-09-12
- Acceptance date:
- 2024-06-14
- DOI:
- EISSN:
-
1549-1676
- ISSN:
-
1549-1277
- Language:
-
English
- Source identifiers:
-
2257096
- Deposit date:
-
2024-09-13
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
If you are the owner of this record, you can report an update to it here: Report update to this record